Prosecution Insights
Last updated: May 29, 2026

Rowan University

10 pending office actions • 10 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
8
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
10
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only7 (70%)
§102 only3 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
40% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
6
Mechanical / Eng
60% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NGUYEN, BAO-THIEU L 1 65.7% +26.2%
MPAMUGO, CHINYERE 1 26.6% +26.9%
DUKE, EMMANUEL E 1 68.5% +27.7%
LAU, JONATHAN S 1 63.8% -18.5%
LANE, DANIEL E 1 4.1% +8.6%
NGUYEN, VI X 1 85.9% +13.3%
DABKOWSKI, ERINNE R 1 55.8% +69.0%
FONTAINHAS, AURORA M 1 37.5% +48.0%
GREENE, IVAN A 1 18.7% +6.6%
STIGELL, THEODORE J 1 78.2% +14.7%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18251166 Synthetic Aligned Tissue Grafts and Methods of Using the Same NGUYEN, VI X 4d overdue

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18739516 MULTI-SESSION SUPPORT SYSTEM FOR HEALTHCARE PROFESSIONALS MPAMUGO, CHINYERE 146d overdue
18443973 AUTOMATED DETECTION OF COGNITIVE CONDITIONS LANE, DANIEL E 91d overdue
17507951 BACTERICIDAL COATING COMPOSITIONS AND METHODS USING SAME GREENE, IVAN A 72d overdue

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18739516 MULTI-SESSION SUPPORT SYSTEM FOR HEALTHCARE PROFESSIONALS MPAMUGO, CHINYERE 146d overdue
17073506 HANDHELD PRINTER FOR CONTROLLED MIXING AND DELIVERY OF MULTI-COMPONENT POLYMERS/BIOMATERIALS STIGELL, THEODORE J 97d overdue
18832559 ASSEMBLY OF POLYMER STAPLE NANOFIBER YARN NGUYEN, BAO-THIEU L 58d overdue
17820815 DIAGNOSTIC BIOMARKERS FOR DETECTING, SUBTYPING, AND/OR ASSESSING PROGRESSION OF MULTIPLE SCLEROSIS FONTAINHAS, AURORA M 18d overdue
18251166 Synthetic Aligned Tissue Grafts and Methods of Using the Same NGUYEN, VI X 4d overdue
18679011 ROOM AIR MONITORING DEVICE DUKE, EMMANUEL E 3d overdue
18032018 METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING COVID-19 INFECTION AND RELATED INFLAMMATION DABKOWSKI, ERINNE R 2d overdue

Top Art Units

Art UnitApps
3732 1
3685 1
3763 1
1693 1
3715 1
3771 1
1654 1
1675 1
1619 1
3783 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18832559 ASSEMBLY OF POLYMER STAPLE NANOFIBER YARN NGUYEN, BAO-THIEU L 3732 §103 Final Rejection 58d overdue Pending Jul 24, 2024
18739516 MULTI-SESSION SUPPORT SYSTEM FOR HEALTHCARE PROFESSIONALS MPAMUGO, CHINYERE 3685 §102 Non-Final OA 146d overdue Pending Jun 11, 2024
18679011 ROOM AIR MONITORING DEVICE DUKE, EMMANUEL E 3763 §103 Non-Final OA 3d overdue Pending May 30, 2024
18673752 METHODS OF MODIFYING CELLULOSE CRYSTALLINITY LAU, JONATHAN S 1693 §102 Non-Final OA 18d overdue Pending May 24, 2024
18443973 AUTOMATED DETECTION OF COGNITIVE CONDITIONS LANE, DANIEL E 3715 §103 Non-Final OA 91d overdue Pending Feb 16, 2024
18251166 Synthetic Aligned Tissue Grafts and Methods of Using the Same NGUYEN, VI X 3771 §103 Non-Final OA 4d overdue Pending Apr 28, 2023
18032018 METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING COVID-19 INFECTION AND RELATED INFLAMMATION DABKOWSKI, ERINNE R 1654 §103 Non-Final OA 2d overdue Pending Apr 14, 2023
17820815 DIAGNOSTIC BIOMARKERS FOR DETECTING, SUBTYPING, AND/OR ASSESSING PROGRESSION OF MULTIPLE SCLEROSIS FONTAINHAS, AURORA M 1675 §102 Non-Final OA 18d overdue Pending Aug 18, 2022
17507951 BACTERICIDAL COATING COMPOSITIONS AND METHODS USING SAME GREENE, IVAN A 1619 §103 Non-Final OA 72d overdue Pending Oct 22, 2021
17073506 HANDHELD PRINTER FOR CONTROLLED MIXING AND DELIVERY OF MULTI-COMPONENT POLYMERS/BIOMATERIALS STIGELL, THEODORE J 3783 §103 Final Rejection 97d overdue Pending Oct 19, 2020

Managing Rowan University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month